Stockscreener 앱 받기
5.555
5.16%
0.325
전일 마감가:
$5.23
열려 있는:
$5.22
하루 거래량:
94,053
Relative Volume:
1.24
시가총액:
$142.53M
수익:
$8.98M
순이익/손실:
$-31.39M
주가수익비율:
-4.1455
EPS:
-1.34
순현금흐름:
$-24.83M
1주 성능:
+15.97%
1개월 성능:
+10.00%
6개월 성능:
-30.47%
1년 성능:
-25.27%
1일 변동 폭
$5.13
$5.5899
1주일 범위
$4.62
$5.5899
52주 변동 폭
$3.895
$11.42
프로파운드 메디컬 Stock (PROF) Company Profile
명칭
Profound Medical Corp
전화
647-476-1350
주소
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
PROF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
5.555 | 142.53M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
132.25 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.50 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
381.94 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.41 | 108.80B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.36 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
프로파운드 메디컬 Stock (PROF) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-23 | 개시 | Lake Street | Buy |
| 2024-07-16 | 업그레이드 | Stifel | Hold → Buy |
| 2023-11-28 | 개시 | Stifel | Hold |
| 2023-08-04 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-09-15 | 개시 | Jefferies | Buy |
모두보기
프로파운드 메디컬 주식(PROF)의 최신 뉴스
Learn to Evaluate (PRN) using the Charts (PRN:CA) - news.stocktradersdaily.com
Strong week for Profound Medical (TSE:PRN) shareholders doesn't alleviate pain of five-year loss - simplywall.st
Press Release Distribution & PR Platform - ACCESS Newswire
Profound Medical: In Serious Trouble Despite Projected Growth (NASDAQ:PROF) - Seeking Alpha
Profound Medical to Present at 2025 Healthcare Investor Conference - TipRanks
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference - The Manila Times
XTX Topco Ltd Buys New Position in Profound Medical Corp. (NASDAQ:PROF) - Defense World
Is Profound Medical a buy right now? - Cantech Letter
Toronto Stocks Flat as Liberals Clinch Fourth Term Government; Profound Medical Shares Up - marketscreener.com
Profound Medical (PROF) Showcases Promising TULSA Procedure Resu - GuruFocus
Profound Medical Corp. - Baystreet.ca
Profound Medical Announces Positive CAPTAIN Trial Results - TipRanks
Profound Medical Brief: Says Provides "Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy" - marketscreener.com
Profound Medical Brief: Detailing Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA - marketscreener.com
Profound Medical Highlights TULSA-PRO at Urology Meeting - TipRanks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp.PROF - PR Newswire
Bank of Montreal Can Decreases Stake in Profound Medical Corp. (NASDAQ:PROF) - Defense World
(PRN) Investment Report (PRN:CA) - news.stocktradersdaily.com
Lake Street Capital Cuts Profound Medical (NASDAQ:PROF) Price Target to $11.00 - Defense World
(PRN) Trading Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical (PROF) Price Target Cut Ahead of Study Release - GuruFocus
Profound Medical (PROF) Price Target Cut Ahead of Study Release | PROF Stock News - GuruFocus
Profound Medical announces annual meeting details By Investing.com - Investing.com India
Profound Medical announces annual meeting details - Investing.com
(PROF) Investment Report - news.stocktradersdaily.com
(PRN) Investment Analysis (PRN:CA) - news.stocktradersdaily.com
Profound Medical to Announce Q1 2025 Financial Results - TipRanks
Profound Medical to Release First Quarter 2025 Financial Results on May 8Conference Call to Follow - The Manila Times
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow - The Spec
With 56% institutional ownership, Profound Medical Corp. (TSE:PRN) is a favorite amongst the big guns - Yahoo Finance
High Intensity Focused Ultrasound (HIFU) Market to Reach $1.81 Billion by 2034, Growing at a CAGR of 10.4% | Rising Demand for Non-Invasive Therapeutic Solutions Driving Global Market Expansion - GlobeNewswire Inc.
Profound Medical AUA 2025 Investor Event Agenda - Lelezard
(PRN) Strategic Investment Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical AUA 2025 Investor Event Agenda | PROF Stock New - GuruFocus
Profound Medical Unveils Agenda for AUA 2025 Investor Event - TipRanks
Profound Medical AUA 2025 Investor Event Agenda | PROF Stock News - GuruFocus
3 Reasons LGIH is Risky and 1 Stock to Buy Instead - The Globe and Mail
(PRN) Equity Trading Insights (PRN:CA) - news.stocktradersdaily.com
(PRN) Investment Analysis and Advice (PRN:CA) - news.stocktradersdaily.com
Profound Medical Corp. (PROF) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com
BKKT Investors Are Reminded of an Opportunity to Lead Bakkt Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
PROF Investors Have Opportunity to Join Profound Medical Corp. Fraud Investigation with the Schall Law Firm - PR Newswire
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Profound Medical stock hits 52-week low at $4.73 amid market challenges By Investing.com - Investing.com South Africa
Profound Medical stock hits 52-week low at $4.73 amid market challenges - Investing.com Australia
Bronstein, Gewirtz & Grossman, LLC Encourages Profound Medical Corp. (PROF) Shareholders to Inquire about Securities Investigation - markets.businessinsider.com
How To Trade (PRN) (PRN:CA) - news.stocktradersdaily.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Profound Medical Corp. (PROF) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Profound Medical Corp. (PROF) And Encourages Shareholders to Reach Out - ACCESS Newswire
PROF Investors Have Opportunity to Join Profound Medical Corp. F - GuruFocus
프로파운드 메디컬 (PROF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
10.11%
0.04%
자본화:
|
볼륨(24시간):